Copyright Reports & Markets. All rights reserved.

Global Calbindin (CB-28KD) PAb Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Calbindin (CB-28KD) PAb Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Rabbit Antibody
    • 1.3.3 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Calbindin (CB-28KD) PAb Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Biomedical Research
    • 1.4.3 Drug Development
    • 1.4.4 Other
  • 1.5 Global Calbindin (CB-28KD) PAb Market Size & Forecast
    • 1.5.1 Global Calbindin (CB-28KD) PAb Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Calbindin (CB-28KD) PAb Sales Quantity (2021-2032)
    • 1.5.3 Global Calbindin (CB-28KD) PAb Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Biosynthesis Biotechnology
    • 2.1.1 Biosynthesis Biotechnology Details
    • 2.1.2 Biosynthesis Biotechnology Major Business
    • 2.1.3 Biosynthesis Biotechnology Calbindin (CB-28KD) PAb Product and Services
    • 2.1.4 Biosynthesis Biotechnology Calbindin (CB-28KD) PAb Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Biosynthesis Biotechnology Recent Developments/Updates
  • 2.2 Santa
    • 2.2.1 Santa Details
    • 2.2.2 Santa Major Business
    • 2.2.3 Santa Calbindin (CB-28KD) PAb Product and Services
    • 2.2.4 Santa Calbindin (CB-28KD) PAb Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Santa Recent Developments/Updates
  • 2.3 Abcam
    • 2.3.1 Abcam Details
    • 2.3.2 Abcam Major Business
    • 2.3.3 Abcam Calbindin (CB-28KD) PAb Product and Services
    • 2.3.4 Abcam Calbindin (CB-28KD) PAb Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Abcam Recent Developments/Updates
  • 2.4 Thermo Fisher Scientific
    • 2.4.1 Thermo Fisher Scientific Details
    • 2.4.2 Thermo Fisher Scientific Major Business
    • 2.4.3 Thermo Fisher Scientific Calbindin (CB-28KD) PAb Product and Services
    • 2.4.4 Thermo Fisher Scientific Calbindin (CB-28KD) PAb Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Thermo Fisher Scientific Recent Developments/Updates
  • 2.5 Merck Millipore
    • 2.5.1 Merck Millipore Details
    • 2.5.2 Merck Millipore Major Business
    • 2.5.3 Merck Millipore Calbindin (CB-28KD) PAb Product and Services
    • 2.5.4 Merck Millipore Calbindin (CB-28KD) PAb Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Merck Millipore Recent Developments/Updates
  • 2.6 Shanghai Huzhen Industry
    • 2.6.1 Shanghai Huzhen Industry Details
    • 2.6.2 Shanghai Huzhen Industry Major Business
    • 2.6.3 Shanghai Huzhen Industry Calbindin (CB-28KD) PAb Product and Services
    • 2.6.4 Shanghai Huzhen Industry Calbindin (CB-28KD) PAb Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Shanghai Huzhen Industry Recent Developments/Updates
  • 2.7 Shanghai Yiyan Biotechnology
    • 2.7.1 Shanghai Yiyan Biotechnology Details
    • 2.7.2 Shanghai Yiyan Biotechnology Major Business
    • 2.7.3 Shanghai Yiyan Biotechnology Calbindin (CB-28KD) PAb Product and Services
    • 2.7.4 Shanghai Yiyan Biotechnology Calbindin (CB-28KD) PAb Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Shanghai Yiyan Biotechnology Recent Developments/Updates
  • 2.8 Yaji Biotechnology
    • 2.8.1 Yaji Biotechnology Details
    • 2.8.2 Yaji Biotechnology Major Business
    • 2.8.3 Yaji Biotechnology Calbindin (CB-28KD) PAb Product and Services
    • 2.8.4 Yaji Biotechnology Calbindin (CB-28KD) PAb Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Yaji Biotechnology Recent Developments/Updates
  • 2.9 Shanghai Yuanmu Biotechnology
    • 2.9.1 Shanghai Yuanmu Biotechnology Details
    • 2.9.2 Shanghai Yuanmu Biotechnology Major Business
    • 2.9.3 Shanghai Yuanmu Biotechnology Calbindin (CB-28KD) PAb Product and Services
    • 2.9.4 Shanghai Yuanmu Biotechnology Calbindin (CB-28KD) PAb Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Shanghai Yuanmu Biotechnology Recent Developments/Updates
  • 2.10 Shanghai Jingkang Bioengineering
    • 2.10.1 Shanghai Jingkang Bioengineering Details
    • 2.10.2 Shanghai Jingkang Bioengineering Major Business
    • 2.10.3 Shanghai Jingkang Bioengineering Calbindin (CB-28KD) PAb Product and Services
    • 2.10.4 Shanghai Jingkang Bioengineering Calbindin (CB-28KD) PAb Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Shanghai Jingkang Bioengineering Recent Developments/Updates
  • 2.11 Beijing Biolab Technology
    • 2.11.1 Beijing Biolab Technology Details
    • 2.11.2 Beijing Biolab Technology Major Business
    • 2.11.3 Beijing Biolab Technology Calbindin (CB-28KD) PAb Product and Services
    • 2.11.4 Beijing Biolab Technology Calbindin (CB-28KD) PAb Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Beijing Biolab Technology Recent Developments/Updates
  • 2.12 Santa Cruz Biotechnology
    • 2.12.1 Santa Cruz Biotechnology Details
    • 2.12.2 Santa Cruz Biotechnology Major Business
    • 2.12.3 Santa Cruz Biotechnology Calbindin (CB-28KD) PAb Product and Services
    • 2.12.4 Santa Cruz Biotechnology Calbindin (CB-28KD) PAb Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Santa Cruz Biotechnology Recent Developments/Updates
  • 2.13 Proteintech
    • 2.13.1 Proteintech Details
    • 2.13.2 Proteintech Major Business
    • 2.13.3 Proteintech Calbindin (CB-28KD) PAb Product and Services
    • 2.13.4 Proteintech Calbindin (CB-28KD) PAb Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Proteintech Recent Developments/Updates
  • 2.14 Novus Biologicals
    • 2.14.1 Novus Biologicals Details
    • 2.14.2 Novus Biologicals Major Business
    • 2.14.3 Novus Biologicals Calbindin (CB-28KD) PAb Product and Services
    • 2.14.4 Novus Biologicals Calbindin (CB-28KD) PAb Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Novus Biologicals Recent Developments/Updates
  • 2.15 GeneTex
    • 2.15.1 GeneTex Details
    • 2.15.2 GeneTex Major Business
    • 2.15.3 GeneTex Calbindin (CB-28KD) PAb Product and Services
    • 2.15.4 GeneTex Calbindin (CB-28KD) PAb Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 GeneTex Recent Developments/Updates
  • 2.16 Boster Bio
    • 2.16.1 Boster Bio Details
    • 2.16.2 Boster Bio Major Business
    • 2.16.3 Boster Bio Calbindin (CB-28KD) PAb Product and Services
    • 2.16.4 Boster Bio Calbindin (CB-28KD) PAb Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Boster Bio Recent Developments/Updates

3 Competitive Environment: Calbindin (CB-28KD) PAb by Manufacturer

  • 3.1 Global Calbindin (CB-28KD) PAb Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Calbindin (CB-28KD) PAb Revenue by Manufacturer (2021-2026)
  • 3.3 Global Calbindin (CB-28KD) PAb Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Calbindin (CB-28KD) PAb by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Calbindin (CB-28KD) PAb Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Calbindin (CB-28KD) PAb Manufacturer Market Share in 2025
  • 3.5 Calbindin (CB-28KD) PAb Market: Overall Company Footprint Analysis
    • 3.5.1 Calbindin (CB-28KD) PAb Market: Region Footprint
    • 3.5.2 Calbindin (CB-28KD) PAb Market: Company Product Type Footprint
    • 3.5.3 Calbindin (CB-28KD) PAb Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Calbindin (CB-28KD) PAb Market Size by Region
    • 4.1.1 Global Calbindin (CB-28KD) PAb Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Calbindin (CB-28KD) PAb Consumption Value by Region (2021-2032)
    • 4.1.3 Global Calbindin (CB-28KD) PAb Average Price by Region (2021-2032)
  • 4.2 North America Calbindin (CB-28KD) PAb Consumption Value (2021-2032)
  • 4.3 Europe Calbindin (CB-28KD) PAb Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Calbindin (CB-28KD) PAb Consumption Value (2021-2032)
  • 4.5 South America Calbindin (CB-28KD) PAb Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Calbindin (CB-28KD) PAb Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Calbindin (CB-28KD) PAb Sales Quantity by Type (2021-2032)
  • 5.2 Global Calbindin (CB-28KD) PAb Consumption Value by Type (2021-2032)
  • 5.3 Global Calbindin (CB-28KD) PAb Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Calbindin (CB-28KD) PAb Sales Quantity by Application (2021-2032)
  • 6.2 Global Calbindin (CB-28KD) PAb Consumption Value by Application (2021-2032)
  • 6.3 Global Calbindin (CB-28KD) PAb Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Calbindin (CB-28KD) PAb Sales Quantity by Type (2021-2032)
  • 7.2 North America Calbindin (CB-28KD) PAb Sales Quantity by Application (2021-2032)
  • 7.3 North America Calbindin (CB-28KD) PAb Market Size by Country
    • 7.3.1 North America Calbindin (CB-28KD) PAb Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Calbindin (CB-28KD) PAb Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Calbindin (CB-28KD) PAb Sales Quantity by Type (2021-2032)
  • 8.2 Europe Calbindin (CB-28KD) PAb Sales Quantity by Application (2021-2032)
  • 8.3 Europe Calbindin (CB-28KD) PAb Market Size by Country
    • 8.3.1 Europe Calbindin (CB-28KD) PAb Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Calbindin (CB-28KD) PAb Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Calbindin (CB-28KD) PAb Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Calbindin (CB-28KD) PAb Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Calbindin (CB-28KD) PAb Market Size by Region
    • 9.3.1 Asia-Pacific Calbindin (CB-28KD) PAb Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Calbindin (CB-28KD) PAb Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Calbindin (CB-28KD) PAb Sales Quantity by Type (2021-2032)
  • 10.2 South America Calbindin (CB-28KD) PAb Sales Quantity by Application (2021-2032)
  • 10.3 South America Calbindin (CB-28KD) PAb Market Size by Country
    • 10.3.1 South America Calbindin (CB-28KD) PAb Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Calbindin (CB-28KD) PAb Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Calbindin (CB-28KD) PAb Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Calbindin (CB-28KD) PAb Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Calbindin (CB-28KD) PAb Market Size by Country
    • 11.3.1 Middle East & Africa Calbindin (CB-28KD) PAb Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Calbindin (CB-28KD) PAb Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Calbindin (CB-28KD) PAb Market Drivers
  • 12.2 Calbindin (CB-28KD) PAb Market Restraints
  • 12.3 Calbindin (CB-28KD) PAb Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Calbindin (CB-28KD) PAb and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Calbindin (CB-28KD) PAb
  • 13.3 Calbindin (CB-28KD) PAb Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Calbindin (CB-28KD) PAb Typical Distributors
  • 14.3 Calbindin (CB-28KD) PAb Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Calbindin (CB-28KD) PAb market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Calcium binding protein D28K polyclonal antibody, referred to as Calbindin D28K polyclonal antibody, is a polyclonal antibody that recognizes and binds to calcium binding protein D28K (Calbindin D28K), which is an important intracellular calcium binding protein that is widely present in the cells of various organisms, especially in neurons and muscle cells. Calbindin D28K polyclonal antibody can specifically recognize and bind to calcium binding protein D28K, and this specificity makes the antibody have a wide range of application value in biomedical research. Unlike monoclonal antibodies, polyclonal antibodies are a mixture of multiple monoclonal antibodies produced by the body after multiple antigenic determinants stimulate the body. This means that polyclonal antibodies can recognize multiple epitopes of antigens, thereby increasing their ability to bind to antigens.
    Calcium-binding protein D28K (Calbindin D28K) is an important intracellular calcium-binding protein that is widely present in a variety of organisms and plays an important role in cell signaling, cell proliferation, apoptosis and other processes. Therefore, calcium-binding protein D28K polyclonal antibodies have broad application prospects in biomedical research, disease diagnosis and treatment. With the continuous deepening of biomedical research, the demand for research on the function and regulatory mechanism of calcium-binding protein D28K is increasing, which has promoted the rapid development of the calcium-binding protein D28K polyclonal antibody market. In addition, with the continuous innovation of biotechnology, the preparation technology of calcium-binding protein D28K polyclonal antibodies is also constantly improving. For example, modifying the antibody structure through genetic engineering technology to improve its affinity, stability and specificity has become one of the current research hotspots. In summary, the calcium-binding protein D28K polyclonal antibody market has broad development prospects and huge market potential. In the future, this market will usher in a more prosperous development situation.
    This report is a detailed and comprehensive analysis for global Calbindin (CB-28KD) PAb market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Calbindin (CB-28KD) PAb market size and forecasts, in consumption value ($ Million), sales quantity (mg), and average selling prices (US$/μg), 2021-2032
    Global Calbindin (CB-28KD) PAb market size and forecasts by region and country, in consumption value ($ Million), sales quantity (mg), and average selling prices (US$/μg), 2021-2032
    Global Calbindin (CB-28KD) PAb market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (mg), and average selling prices (US$/μg), 2021-2032
    Global Calbindin (CB-28KD) PAb market shares of main players, shipments in revenue ($ Million), sales quantity (mg), and ASP (US$/μg), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Calbindin (CB-28KD) PAb
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Calbindin (CB-28KD) PAb market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biosynthesis Biotechnology, Santa, Abcam, Thermo Fisher Scientific, Merck Millipore, Shanghai Huzhen Industry, Shanghai Yiyan Biotechnology, Yaji Biotechnology, Shanghai Yuanmu Biotechnology, Shanghai Jingkang Bioengineering, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Calbindin (CB-28KD) PAb market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Rabbit Antibody
    Other
    Market segment by Application
    Biomedical Research
    Drug Development
    Other
    Major players covered
    Biosynthesis Biotechnology
    Santa
    Abcam
    Thermo Fisher Scientific
    Merck Millipore
    Shanghai Huzhen Industry
    Shanghai Yiyan Biotechnology
    Yaji Biotechnology
    Shanghai Yuanmu Biotechnology
    Shanghai Jingkang Bioengineering
    Beijing Biolab Technology
    Santa Cruz Biotechnology
    Proteintech
    Novus Biologicals
    GeneTex
    Boster Bio
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Calbindin (CB-28KD) PAb product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Calbindin (CB-28KD) PAb, with price, sales quantity, revenue, and global market share of Calbindin (CB-28KD) PAb from 2021 to 2026.
    Chapter 3, the Calbindin (CB-28KD) PAb competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Calbindin (CB-28KD) PAb breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Calbindin (CB-28KD) PAb market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Calbindin (CB-28KD) PAb.
    Chapter 14 and 15, to describe Calbindin (CB-28KD) PAb sales channel, distributors, customers, research findings and conclusion.

    Buy now